abstract |
The invention provides a human C-kinase inhibitor (HPKCI) and polynucleotides which identify and encode HPKCI. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of HPKCI. |